Intravitreal injections (IVI) have become the most common intraocular procedure worldwide
with increasing numbers every year. The article presents the most up-to-date review on IVI …

Although once daily anti-glaucoma drug therapy is a current clinical reality, most therapies
require multiple dosing and there is an unmet need to develop convenient, safe, and …

Purpose: To review evidence and provide updated guidelines on intravitreal (IVT) injection
technique and monitoring. Methods: A review of the published literature on IVT injection from …

Intravitreal injections have become the most commonly performed intraocular treatments
worldwide. Because intravitreal injections may induce severe adverse events, such as …

Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

The purpose of this review is to report and summarize previously reported studies and
assess many of the individual steps of the intravitreal injection procedure's possible effect on …

Even though the very thought of an injection into the eye may be frightening, an estimated 6
million intravitreal (IVT) injections were made in the USA during 2016. With the introduction …

Artificial vitreous humor holds immense potential for use in in vitro intravitreal drug delivery
assays. In this study, we investigated rheological properties and drug or nanoparticle …

Purpose: To determine factors associated with patients' comfort during routine in-office
intravitreal injection. Methods: Sixty patients receiving intravitreal injections over 15 months …

The majority of blinding conditions arise due to chronic pathologies in the retina. During the
last two decades, antibody-based medicines administered by intravitreal injection directly …